This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bhushan, A Articles by Kintner, C R Search for Related Content PubMed PubMed Citation Articles by Bhushan, A Articles by Kintner, C R

The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm.

Molecular Neurobiology Laboratory, Salk Institute, La Jolla, California 92037.

ABSTRACT

The type II receptors for the polypeptide growth factors transforming growth factor beta (TGF-beta) and activin belong to a new family of predicted serine/threonine protein kinases. In Xenopus embryos, the biological effects of activin and TGF-beta 1 are strikingly different; activin induces a full range of mesodermal cell types in the animal cap assay, while TGF-beta 1 has no effects, presumably because of the lack of functional TGF-beta receptors. In order to assess the biological activities of exogenously added TGF-beta 1, RNA encoding the TGF-beta type II receptor was introduced into Xenopus embryos. In animal caps from these embryos, TGF-beta 1 and activin show similar potencies for induction of mesoderm-specific mRNAs, and both elicit the same types of mesodermal tissues. In addition, the response of animal caps to TGF-beta 1, as well as to activin, is blocked by a dominant inhibitory ras mutant, p21(Asn-17)Ha-ras. These results indicate that the activin and TGF-beta type II receptors can couple to similar signalling pathways and that the biological specificities of these growth factors lie in their different ligand-binding domains and in different competences of the responding cells.

This article has been cited by other articles:

• Lücke, C. D., Philpott, A., Metcalfe, J. C., Thompson, A. M., Hughes-Davies, L., Kemp, P. R., Hesketh, R. (2001). Inhibiting Mutations in the Transforming Growth Factor {beta} Type 2 Receptor in Recurrent Human Breast Cancer. Cancer Res. 61: 482-485 [Abstract] [Full Text]  
• Bang, A. G., Kintner, C. (2000). Rhomboid and Star facilitate presentation and processing of the Drosophila TGF-alpha homolog Spitz. Genes Dev. 14: 177-186 [Abstract] [Full Text]  
• George, J., Roulot, D., Koteliansky, V. E., Bissell, D. M. (1999). In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis. Proc. Natl. Acad. Sci. USA 96: 12719-12724 [Abstract] [Full Text]  
• Frisch, A, Wright, C. (1998). XBMPRII, a novel Xenopus type II receptor mediating BMP signaling in embryonic tissues. Development 125: 431-442 [Abstract]  
• Chen, Y., Bhushan, A., Vale, W. (1997). Smad8 mediates the signaling of the receptor serine kinase. Proc. Natl. Acad. Sci. USA 94: 12938-12943 [Abstract] [Full Text]  
• Bang, A., Papalopulu, N, Kintner, C, Goulding, M. (1997). Expression of Pax-3 is initiated in the early neural plate by posteriorizing signals produced by the organizer and by posterior non-axial mesoderm. Development 124: 2075-2085 [Abstract]  
• Hartsough, M. T., Frey, R. S., Zipfel, P. A., Buard, A., Cook, S. J., McCormick, F., Mulder, K. M. (1996). Altered Transforming Growth Factor beta Signaling in Epithelial Cells when Ras Activation Is Blocked. J. Biol. Chem. 271: 22368-22375 [Abstract] [Full Text]  
• Hartsough, M. T., Mulder, K. M. (1995). Transforming Growth Factor beta Activation of p44[IMAGE] in Proliferating Cultures of Epithelial Cells. J. Biol. Chem. 270: 7117-7124 [Abstract] [Full Text]  
• Lin, H. Y., Moustakas, A., Knaus, P., Wells, R. G., Henis, Y. I., Lodish, H. F. (1995). The Soluble Exoplasmic Domain of the Type II Transforming Growth Factor (TGF)-beta Receptor. J. Biol. Chem. 270: 2747-2754 [Abstract] [Full Text]  
• Moustakas, A., Takumi, T., Lin, H. Y., Lodish, H. F. (1995). GH3 Pituitary Tumor Cells Contain Heteromeric Type I and Type II Receptor Complexes for Transforming Growth Factor beta and Activin-A. J. Biol. Chem. 270: 765-769 [Abstract] [Full Text]  
• Ataliotis, P, Symes, K, Chou, M., Ho, L, Mercola, M (1995). PDGF signalling is required for gastrulation of Xenopus laevis. Development 121: 3099-3110 [Abstract]